[HTML][HTML] Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara, L Xu, M Maki… - BMC neuroscience, 2009 - Springer
Background Minocycline, a second-generation tetracycline with anti-inflammatory and anti-
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara, L Xu, M Maki… - BMC …, 2009 - go.gale.com
Background Cerebral ischemia triggers a cascade of pathophysiological events including
excitotoxicity, ionic imbalance, oxidative and nitrosative stresses and apoptotic-like cell …
excitotoxicity, ionic imbalance, oxidative and nitrosative stresses and apoptotic-like cell …
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara, L Xu… - BMC …, 2009 - augusta.elsevierpure.com
Background: Minocycline, a second-generation tetracycline with anti-inflammatory and anti-
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
[PDF][PDF] Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara, L Xu… - BMC …, 2009 - researchgate.net
Background: Minocycline, a second-generation tetracycline with anti-inflammatory and
antiapoptotic properties, has been shown to promote therapeutic benefits in experimental …
antiapoptotic properties, has been shown to promote therapeutic benefits in experimental …
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.
N Matsukawa, T Yasuhara, K Hara, L Xu… - BMC …, 2009 - psycnet.apa.org
Background: Minocycline, a second-generation tetracycline with anti-inflammatory and
antiapoptotic properties, has been shown to promote therapeutic benefits in experimental …
antiapoptotic properties, has been shown to promote therapeutic benefits in experimental …
[HTML][HTML] Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara, L Xu… - BMC …, 2009 - ncbi.nlm.nih.gov
Background Minocycline, a second-generation tetracycline with anti-inflammatory and anti-
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.
N Matsukawa, T Yasuhara, K Hara, L Xu, M Maki… - BMC …, 2009 - europepmc.org
Background Minocycline, a second-generation tetracycline with anti-inflammatory and anti-
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara… - BMC …, 2009 - okayama.elsevierpure.com
Background: Minocycline, a second-generation tetracycline with anti-inflammatory and anti-
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
apoptotic properties, has been shown to promote therapeutic benefits in experimental …
[HTML][HTML] Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara… - BMC …, 2009 - bmcneurosci.biomedcentral.com
Minocycline, a second-generation tetracycline with anti-inflammatory and anti-apoptotic
properties, has been shown to promote therapeutic benefits in experimental stroke …
properties, has been shown to promote therapeutic benefits in experimental stroke …
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
N Matsukawa, T Yasuhara, K Hara, L Xu, M Maki… - BMC …, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Minocycline, a second-generation tetracycline with anti-inflammatory and anti-apoptotic …
Minocycline, a second-generation tetracycline with anti-inflammatory and anti-apoptotic …